These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 3283237)
1. Demonstration of a specific C3a receptor on guinea pig platelets. Fukuoka Y; Hugli TE J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237 [TBL] [Abstract][Full Text] [Related]
2. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes. Gerardy-Schahn R; Ambrosius D; Saunders D; Casaretto M; Mittler C; Karwarth G; Görgen S; Bitter-Suermann D Eur J Immunol; 1989 Jun; 19(6):1095-102. PubMed ID: 2666143 [TBL] [Abstract][Full Text] [Related]
3. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control. Fukuoka Y; Hugli TE J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312 [TBL] [Abstract][Full Text] [Related]
4. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan. Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005 [TBL] [Abstract][Full Text] [Related]
5. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets. Zanker B; Rasokat H; Hadding U; Bitter-Suermann D Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary injury induced by C3a and C5a anaphylatoxins. Stimler NP; Hugli TE; Bloor CM Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702 [TBL] [Abstract][Full Text] [Related]
7. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets. Becker S; Hadding U; Schorlemmer HU; Bitter-Suermann D Scand J Immunol; 1978; 8(6):551-5. PubMed ID: 734357 [TBL] [Abstract][Full Text] [Related]
8. Platelet-serotonin release by C3a and C5a: two independent pathways of activation. Meuer S; Ecker U; Hadding U; Bitter-Suermann D J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes. van Epps DE; Chenoweth DE J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920 [TBL] [Abstract][Full Text] [Related]
10. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release. Glovsky MM; Hugli TE; Ishizaka T; Lichtenstein LM; Erickson BW J Clin Invest; 1979 Sep; 64(3):804-11. PubMed ID: 89118 [TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop. Fukuoka Y; Ember JA; Hugli TE J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361 [TBL] [Abstract][Full Text] [Related]
12. Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-gamma. Molinas FC; Wietzerbin J; Falcoff E J Immunol; 1987 Feb; 138(3):802-6. PubMed ID: 2949008 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the C5a receptor on guinea pig platelets. Kretzschmar T; Kahl K; Rech K; Bautsch W; Köhl J; Bitter-Suermann D Immunobiology; 1991 Nov; 183(5):418-32. PubMed ID: 1786990 [TBL] [Abstract][Full Text] [Related]
14. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion. Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935 [TBL] [Abstract][Full Text] [Related]
15. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin. Scandura JM; Ahmad SS; Walsh PN Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of a novel low affinity complement C3dg-binding protein of human platelets. Chen H; Marjan J; Cox AD; Devine DV J Immunol; 1994 Feb; 152(3):1332-8. PubMed ID: 8301135 [TBL] [Abstract][Full Text] [Related]
17. Uptake of 125I-labelled C3a by cultured human endothelial cells. Denney JB; Johnson AR Immunology; 1979 Feb; 36(2):169-77. PubMed ID: 437829 [TBL] [Abstract][Full Text] [Related]
18. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618 [TBL] [Abstract][Full Text] [Related]
19. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody. Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585 [TBL] [Abstract][Full Text] [Related]
20. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]